Pasithea Therapeutics Corp. (KTTA)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 45
-0.01
-1.5317%
$
3.59M Market Cap
- P/E Ratio
- Div Yield
195,600 Volume
0 Eps
$ 0.46
Previous Close 
Want to track KTTA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Pasithea Therapeutics Corp. (KTTA) Statistics
Valuation metrics
Market Cap 3.59M
Enterprise value -47.05M
Trailing P/E (ttm) -0.19
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.06
Enterprise Value/Revenue -
Enterprise Value/EBITDA 2.2
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 195.53K
Average volume (90 days) 367.49K
Price summary
52-Week low 0.28
52-Week high 2.06
Beta -
50-Day moving average 0.54
200-Day moving average 0.8
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 2 Jan 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.35%
Return on equity -0.57%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.81
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.17
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 35.4%
Book value per share (mrq) 7.8
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
